TCF21 Protects Heart Against Fibrosis 04/05/26

Welcome to Cardiology Today – Recorded April 05, 2026. This episode summarizes 5 key cardiology studies on topics like wall thickness heterogeneity and hypertrophic cardiomyopathy. Key takeaway: TCF21 Protects Heart Against Fibrosis. Article Links: Article 1: Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients. (Cardiovascular research) Article 2: Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. (Cardiovascular research) Article 3: How Accurate Is Inpatient Blood Pressure Measurement? (Hypertension (Dallas, Tex. : 1979)) Article 4: Epicardial-to-Endocardial Activation Gradients and Conduction Block During Atrial Fibrillation in the Human Left Atrial Posterior Wall. (Circulation. Arrhythmia and electrophysiology) Article 5: MRI-derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. (European heart journal. Cardiovascular Imaging) Full episode page: https://podcast.explainheart.com/podcast/tcf21-protects-heart-against-fibrosis-04-05-26/ Featured Articles Article 1: Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41928451 Summary: This study revealed a homogenization of the right and left atrial proteomes in patients with persistent atrial fibrillation. Researchers used a proteomic approach to investigate atrial fibrillation-associated remodeling in the right atrium relative to the left atrium. The data showed that protein profiles in both atria become similar during persistent atrial fibrillation. This finding indicates widespread atrial remodeling extending beyond the left atrium in this patient population. Article 2: Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41926244 Summary: Single nucleus R. N. A. sequencing and functional in vivo studies demonstrated that TCF21 acts as a protective regulator in cardiac fibrosis. This research specifically identified TCF21 as a novel cell-specific candidate gene involved in cardiac fibrosis. The study validated the functional impact of TCF21 using both in vitro and in vivo models. These findings offer a significant breakthrough for cardiac fibrosis, an untreatable contributor to mortality in chronic heart disease. Article 3: How Accurate Is Inpatient Blood Pressure Measurement? Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41930396 Summary: Observations were conducted across three noncritical care wards: aged care, acute surgical, and hematology, over a three-week period. The investigation revealed that no existing guidelines for accurate inpatient blood pressure measurement are currently in place. This highlights a critical need for standardized quality techniques in this clinical setting. Article 4: Epicardial-to-Endocardial Activation Gradients and Conduction Block During Atrial Fibrillation in the Human Left Atrial Posterior Wall. Journal: Circulation. Arrhythmia and electrophysiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41930410 Summary: This study characterized endocardial and epicardial left atrial posterior wall activation in humans during atrial fibrillation. Researchers identified epicardial-to-endocardial activation gradients and conduction blocks within the left atrial posterior wall. The findings demonstrated the prevalence of asynchronous endocardial-epicardial conduction in this region for patients with symptomatic nonparoxysmal atrial fibrillation. This research provides crucial insights into three-dimensional myocardial activation patterns during atrial fibrillation. Article 5: MRI-derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. Journal: European heart journal. Cardiovascular Imaging PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41923453 Summary: R. I. derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. This study demonstrated that wall thickness standard deviation, reflecting wall thickness heterogeneity, improves the identification of hypertrophic cardiomyopathy and sarcomere mutation carriers. Researchers utilized cardiac magnetic resonance imaging in 382 healthy controls, 297 patients with hypertrophic cardiomyopathy, and 82 sarcomere mutation carriers. The data showed that this measure helps identify early or subtle phenotypes missed by absolute wall thickness cut-offs. This method enhances diagnostic capabilities, particularly for mutation carriers. Transcript Today’s date is April 05, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients. This study revealed a homogenization of the right and left atrial proteomes in patients with persistent atrial fibrillation. Researchers used a proteomic approach to investigate atrial fibrillation-associated remodeling in the right atrium relative to the left atrium. The data showed that protein profiles in both atria become similar during persistent atrial fibrillation. This finding indicates widespread atrial remodeling extending beyond the left atrium in this patient population. Article number two. Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. Single nucleus R. N. A. sequencing and functional in vivo studies demonstrated that TCF21 acts as a protective regulator in cardiac fibrosis. This research specifically identified TCF21 as a novel cell-specific candidate gene involved in cardiac fibrosis. The study validated the functional impact of TCF21 using both in vitro and in vivo models. These findings offer a significant breakthrough for cardiac fibrosis, an untreatable contributor to mortality in chronic heart disease. Article number three. How Accurate Is Inpatient Blood Pressure Measurement? This study assessed the performance of routine blood pressure measurements in a major teaching hospital. Observations were conducted across three noncritical care wards: aged care, acute surgical, and hematology, over a three-week period. The investigation revealed that no existing guidelines for accurate inpatient blood pressure measurement are currently in place. This highlights a critical need for standardized quality techniques in this clinical setting. Article number four. Epicardial-to-Endocardial Activation Gradients and Conduction Block During Atrial Fibrillation in the Human Left Atrial Posterior Wall. This study characterized endocardial and epicardial left atrial posterior wall activation in humans during atrial fibrillation. Researchers identified epicardial-to-endocardial activation gradients and conduction blocks within the left atrial posterior wall. The findings demonstrated the prevalence of asynchronous endocardial-epicardial conduction in this region for patients with symptomatic nonparoxysmal atrial fibrillation. This research provides crucial insights into three-dimensional myocardial activation patterns during atrial fibrillation. Article number five. M. R. I. derived Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations. This study demonstrated that wall thickness standard deviation, reflecting wall thickness heterogeneity, improves the identification of hypertrophic cardiomyopathy and sarcomere mutation carriers. Researchers utilized cardiac magnetic resonance imaging in 382 healthy controls, 297 patients with hypertrophic cardiomyopathy, and 82 sarcomere mutation carriers. The data showed that this measure helps identify early or subtle phenotypes missed by absolute wall thickness cut-offs. This method enhances diagnostic capabilities, particularly for mutation carriers. Thank you for listening. Don’t forget to subscribe. Keywords wall thickness heterogeneity, hypertrophic cardiomyopathy, single nucleus R. N. A. sequencing, atrial fibrillation, blood pressure measurement, epicardial, persistent atrial fibrillation, sarcomere gene mutations, proteome profiling, conduction block, diagnostic criteria, left atrial posterior wall, left atrium, TCF21, right atrium, measurement accuracy, protective regulator, endocardial, hospital practice, clinical guidelines, cardiac magnetic resonance, aortic stenosis, inpatient care, cardiac fibrosis. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post TCF21 Protects Heart Against Fibrosis 04/05/26 first appeared on Cardiology Today.